Yigal Nochomovitz
Stock Analyst at Citigroup
(3.07)
# 1,311
Out of 4,711 analysts
284
Total ratings
40.53%
Success rate
1.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRUS Merus | Maintains: Buy | $89 → $97 | $41.85 | +131.78% | 16 | Dec 9, 2024 | |
| APLT Applied Therapeutics | Maintains: Buy | $13 → $8 | $0.88 | +808.99% | 10 | Nov 29, 2024 | |
| CRBU Caribou Biosciences | Maintains: Buy | $30 → $6 | $1.80 | +233.33% | 5 | Nov 26, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $37 → $45 | $13.08 | +244.04% | 7 | Nov 19, 2024 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $40 → $49 | $17.09 | +186.72% | 10 | Nov 12, 2024 | |
| APLS Apellis Pharmaceuticals | Maintains: Buy | $63 → $51 | $33.21 | +53.57% | 14 | Nov 6, 2024 | |
| KRYS Krystal Biotech | Maintains: Neutral | $204 → $206 | $164.83 | +24.98% | 3 | Nov 5, 2024 | |
| ARDX Ardelyx | Maintains: Buy | $12 → $10 | $4.82 | +107.47% | 14 | Nov 4, 2024 | |
| ZYME Zymeworks | Maintains: Buy | $16 → $18 | $14.14 | +27.30% | 15 | Nov 4, 2024 | |
| ZBIO Zenas BioPharma | Initiates: Buy | $27 | $10.01 | +169.73% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.15 | +73.91% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 → $23 | $17.87 | +28.71% | 4 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $26.09 | +37.98% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $25.61 | +126.47% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $4.23 | +420.09% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $3.18 | +340.25% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $288 | $176.50 | +63.17% | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.00 | +20.11% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $15.50 | +145.16% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $84 | $40.72 | +106.29% | 20 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $8.21 | +70.52% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.63 | -23.95% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $32.63 | +4.20% | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $26.72 | +147.01% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $36 → $55 | $18.48 | +197.62% | 8 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $15.48 | +210.08% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.10 | +227.87% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $4.88 | +63.93% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $11.40 | +207.02% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $44.22 | +200.77% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.71 | +1,019.35% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.96 | +525.13% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.64 | +875.61% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.68 | +495.24% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.51 | +959.60% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.34 | +1,217.33% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.05 | +485.37% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.75 | - | 14 | Sep 28, 2021 |
Merus
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $41.85
Upside: +131.78%
Applied Therapeutics
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.88
Upside: +808.99%
Caribou Biosciences
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $1.80
Upside: +233.33%
Syndax Pharmaceuticals
Nov 19, 2024
Maintains: Buy
Price Target: $37 → $45
Current: $13.08
Upside: +244.04%
Rigel Pharmaceuticals
Nov 12, 2024
Maintains: Buy
Price Target: $40 → $49
Current: $17.09
Upside: +186.72%
Apellis Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $33.21
Upside: +53.57%
Krystal Biotech
Nov 5, 2024
Maintains: Neutral
Price Target: $204 → $206
Current: $164.83
Upside: +24.98%
Ardelyx
Nov 4, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $4.82
Upside: +107.47%
Zymeworks
Nov 4, 2024
Maintains: Buy
Price Target: $16 → $18
Current: $14.14
Upside: +27.30%
Zenas BioPharma
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $10.01
Upside: +169.73%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.15
Upside: +73.91%
Sep 27, 2024
Downgrades: Neutral
Price Target: $19 → $23
Current: $17.87
Upside: +28.71%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $26.09
Upside: +37.98%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $25.61
Upside: +126.47%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $4.23
Upside: +420.09%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $3.18
Upside: +340.25%
Aug 8, 2024
Maintains: Buy
Price Target: $269 → $288
Current: $176.50
Upside: +63.17%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.00
Upside: +20.11%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $15.50
Upside: +145.16%
May 23, 2024
Maintains: Buy
Price Target: $89 → $84
Current: $40.72
Upside: +106.29%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $8.21
Upside: +70.52%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.63
Upside: -23.95%
Apr 10, 2024
Initiates: Buy
Price Target: $34
Current: $32.63
Upside: +4.20%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $26.72
Upside: +147.01%
Feb 15, 2024
Downgrades: Neutral
Price Target: $36 → $55
Current: $18.48
Upside: +197.62%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $15.48
Upside: +210.08%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $6.10
Upside: +227.87%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $4.88
Upside: +63.93%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $11.40
Upside: +207.02%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $44.22
Upside: +200.77%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.71
Upside: +1,019.35%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.96
Upside: +525.13%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.64
Upside: +875.61%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.68
Upside: +495.24%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $1.51
Upside: +959.60%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.34
Upside: +1,217.33%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.05
Upside: +485.37%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.75
Upside: -